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 Abstract 
  Aim:   To determine the change in cognitive function in very elderly men with chronic obstruc-
tive pulmonary disease (COPD) over a 3-year period relative to age- and education-matched 
controls.   Methods:   In this hospital-based, prospective case-control study, we evaluated a con-
secutive series of 110 very elderly men with COPD and 110 control subjects who were hospital-
ized between January and December 2007. All the subjects performed cognitive tests at base-
line and underwent annual evaluations (for 3 years), which included the Mini-Mental State 
Examination, word list recall, delayed recall, animal category fluency, and the symbol digit mo-
dalities test.   Results:   In mixed-effects models adjusted for hypertension and coronary heart 
disease, COPD was associated with a more rapid rate of cognitive decline based on the Mini-
Mental State Examination, word list recall, delayed recall, animal category fluency, and the sym-
bol digit modalities test (all p  !  0.01) compared to controls.  Conclusion:  COPD is associated with 
a more rapid rate of cognitive decline in very elderly persons.    Copyright © 2012 S. Karger AG, Basel 
 Introduction 
  With an aging population on the rise worldwide and a shift from an acute to a chronic 
disease burden, the incidence and prevalence of cognitive impairment, such as Alzheimer’s 
disease (AD) and vascular dementia (VD), are expected to increase in the coming decades 
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 [1, 2] . Cognitive dysfunction is associated with increased mortality and disability, and main-
tenance of cognitive function is an important component for successful aging  [3] . As a result, 
prevention of cognitive impairment through risk factor identification and modification has 
profound clinical significance   [4]  . Chronic obstructive pulmonary disease (COPD) is a 
multi-component disease that is common in the elderly  [5, 6] . In addition to these pulmonary 
abnormalities, COPD is also associated with significant effects in distant organs outside the 
lungs, the so-called extrapulmonary effects. These systemic effects add to the morbidity of 
affected patients and should be considered in the clinical assessment, as well as the treatment 
 [7] . The majority of studies, but not all, have shown that patients with COPD have significant 
cognitive impairment, either globally or in domains, such as perception, memory, and psy-
chomotor functions   [8–16]  . However, there have been few longitudinal studies examining 
the association of COPD with the course of cognitive decline. One recent population-based 
longitudinal study showed that severe COPD is associated with lower cognitive performance 
on standardized measurements over time   [17]  . Nonetheless, the clinical diagnosis of COPD 
and comorbidities based on self-report lack sensitivity and reliability, and applying cognitive 
screening instruments did not permit an in-depth examination of cognitive function. The 
participants of our study were retired male veterans with free medical care, similar social 
and educational backgrounds and lifestyle habits. These hospital-based participants provid-
ed an excellent opportunity to examine the change in cognitive function in the elderly. Our 
study evaluated cognitive performance in patients with COPD over a 3-year period relative 
to control participants. We hypothesized that COPD is associated with accelerated cognitive 
decline.
  M e t h o d s  
 Study  Settings 
  All the participants were retired male military officers aged   6  75 years and were regis-
tered at retirement. The cohort consisted of nearly 40 veteran convalescent camps in Nan-
jing, China, which serviced approximately 5,000 retired male military officers of high rank. 
Each camp had nurses and clinicians who cared for the elderly and interacted with physi-
cians at the Jinling Hospital of the Nanjing University School of Medicine when necessary. 
All the elderly living in the long-term care system had received free medical examinations 
and treatment, as well as hospitalization in the Jinling Hospital. The retired male military 
officers underwent an overall physical examination once per year after which   1 65%  were 
hospitalized. The study was approved by the Institutional Review Board of the Jinling Hos-
pital. All subjects signed an informed consent.
  C a s e s  
  All the patients with COPD who were hospitalized in a 200-bed geriatric ward of the 
Jinling Hospital between January and December 2007 were systematically and prospective-
ly screened for inclusion in our study irrespective of the indication for hospital admission. 
On admission, all patients underwent a routine medical examination, including standard 
blood tests, chest X-ray, electrocardiogram, brain MRI or CT scan, and ultrasound exami-
nation. The study physicians confirmed the diagnosis of COPD by applying standardized 
criteria to medical data, hospitalization records, and spirometry results (forced expiratory 
volume in 1 s [FEV1]/forced vital capacity [FVC]   !  0.7 and FEV1   !  80% of predicted). Dur-
ing hospitalization, the following clinical data were documented: demographic character-
istics; medications used; history of heart disease (angina, myocardial infarction, atrial fi-
brillation, and chronic heart failure), hypertension, cancer, diabetes mellitus, and chronic 221
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renal disease. Depressive symptoms were assessed using the Hamilton Depression Scale. A 
global summary score on the Clinical Dementia Rating (CDR) was also assigned. Inclusion 
in the study required the following criteria: (1) patients had to be in a stable condition with 
no physical findings or symptoms suggestive of acute exacerbation before cognitive func-
tion testing, and (2) they had to be in a relatively healthy condition without oxygen depen-
dence. The exclusion criteria included the following: (1) a diagnosis of major neurologic or 
psychotic disorders (e.g. Parkinson disease, dementia, clinical stroke, or depression); (2) 
taking medications with potentially potent central nervous system effects (e.g. sedatives or 
anti-psychotics); (3) considerable hearing or sight disabilities, and (4) major chronic medical 
illness that could affect cognitive function (cancer, diabetes mellitus, renal disease, atrial 
fibrillation, and chronic heart failure). Because hypertension and coronary heart disease 
(angina and myocardial infarction) are extremely common in elderly patients, they were not 
included in the exclusion criteria. The initial eligible cases included 113 elderly males.
  C o n t r o l s  
  Controls were selected from the elderly who were admitted for general health examina-
tions in the same geriatric wards during the same study periods as the COPD patients. The 
clinical evaluation and detailed examination for the controls was the same as for the cases. 
The control subjects were matched for the following characteristics: (1) age within 1 year, (2) 
educational level, and (3) admission date within 30 days. Elderly subjects who were in a rela-
tively good health status were included as controls. The exclusion criteria for the case group 
were also applied to the selection of the control group.
    Measurement of Cognitive Function 
 Trained examiners carried out the following cognitive tests in a quiet room of a geriatric 
ward. We used the Chinese version of the Mini-Mental State Examination (MMSE)   [18]   to 
measure global cognitive functioning with summed scores ranging from 0 to 30. For the 
word list recall (immediate recall)   [18, 19]  , a 10-word list was presented and free recall as-
sessed across three trials with the words being presented in a different order for each trial. 
The list was presented in random order on three successive occasions. After each occasion, 
the participant reported all the words he could recall. The scoring range on each trial was 
0–10; the total score was 30 for the three trials. The animal category fluency   [18, 19]   assesses 
language, verbal fluency, and executive functioning by asking the subject to name as many 
animals as possible within 1 min. The test score was the total number of animals named. In 
the symbol digit modalities test   [18, 19]  , the subject has to translate the numbers 1–9 into 
symbols within 90 s. The test score is the total number of correct translations to symbols 
within the set time. Word delayed recall   [18, 19]   for the 10 words in the word list (immediate 
recall) test was assessed 5 min after the third trial on immediate memory, with a scoring 
range of 0–10.
  F o l l o w - U p  
  Every participant was followed annually for 3 years after the initial cognitive perfor-
mance. Because 2 patients with COPD and 1 control subject died before the first follow-up 
evaluation, 3 patients with COPD (2 COPD patient deaths and 1 patient matched for the con-
trol patient death) and 3 control participants (1 control patient death and 2 control patients 
matched for the 2 COPD patient deaths) were excluded from the study. Thus, 220 persons 
(110 patients and 110 control subjects) were eligible for follow-up and were used in the final 
analysis. During the 3 years of follow-up, the frequency and cause of hospitalizations for pa-
tients with COPD and control subjects were also recorded.222
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  Statistical  Analysis 
  We used a series of linear mixed-effects models to examine the effects of COPD at base-
line and the annual rate of change (fixed effects) in cognition during the study period, while 
adjusting for person-specific paths of change with random effects. In this growth curve ap-
proach, the path of each individual is assumed to follow the mean path of the group, except 
for random effects that cause the initial level of function (i.e. intercept) to be higher or lower 
and the rate of change (i.e. slope) to be faster or slower. We constructed separate mixed-ef-
fects models for each of the cognitive test scores. Each model included terms for time (years 
since baseline), the presence of COPD, and the interaction. The term for time indicates the 
average annual change in the score for control subjects. The term for COPD denotes the av-
erage difference in the baseline score between patients with COPD and the control group. 
The interaction term (COPD   !   time) indicates the average additional annual change in the 
score associated with having COPD. All analyses were adjusted for hypertension and coro-
nary heart disease. Statistical analyses were performed using Stata 10 (StataCorp., College 
Station, Tex., USA). All reported p values were two-sided, and the results were considered 
statistically significant at p   ! 0.05.
  R e s u l t s  
  Baseline Characteristics of the Two Groups 
 The baseline characteristics of the elderly with COPD and the controls were well-matched 
for age, education and body mass index (BMI) at baseline, but there were more patients with 
hypertension (p = 0.023) and coronary heart disease (p = 0.04) among those with COPD 
compared to controls. The COPD patients had poorer baseline cognitive scores on the word 
list recall (p = 0.018), animal fluency (p = 0.022), and symbol digit tests (p = 0.014), but the 
scores of MMSE and delayed recall were not different between the two groups (p   1   0.05;   ta-
ble 1 ).
Table 1.   Baseline characteristics of the patients with COPD and the control group at baseline
COPD 
(n = 110)
Control group 
(n = 110)
p value
Age, years 80.981.78 80.881.59 0.720
Educational level, %
≤5 years 17 (15.5) 17 (15.5) matched
6–9 years 72 (65.5) 72 (65.5) matched
>10 years 21 (19.1) 21 (19.1) matched
BMI 22.382.5 22.882.7 0.225
Hypertension 81 (73.6) 64 (58.2) 0.023
Coronary heart disease 54 (49.1) 38 (34.5) 0.040
MMSE 27.181.67 27.381.59 0.458
Word list recall 16.182.89 17.082.61 0.018
Delayed recall 5.281.18 5.581.29 0.116
Animal fluency 14.282.09 14.882.25 0.022
Symbol digit 23.185.26 24.683.76 0.014
D  ata are presented as the mean 8 SD or n (%). 
p values were determined using a paired t test and the 2 analysis.223
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  F o l l o w - U p  
  During the follow-up, 209 subjects (95%) completed two reassessments of cognitive 
function, and 205 subjects (93%) completed three reassessments of cognitive function. Dur-
ing the 3 years of follow-up, the mean frequency of hospitalization per subject did not differ 
significantly between the case and control groups (2.9   8   1.4 vs. 2.7   8   1.2, p = 0.152). How-
ever, the principal indication for hospital admission (85% of the total number of hospitaliza-
tions) for the COPD group was exacerbation of COPD as a primary diagnosis, while for con-
trol subjects, completion of a routine physical examination and common chronic complaints 
(dizziness or fatigue) were the most common indications for hospital admissions (83% of the 
total number of hospitalizations).
    Relationship between COPD and Level of and Change in Cognitive Tests 
  We examined the associations between cognition in the COPD patients at baseline and 
the annual decline in cognitive scores using a mixed-effects model that controls for hyper-
tension and coronary heart disease (  table 2  ). At baseline, subjects with COPD had lower 
scores than controls on the word list recall (p = 0.016), animal fluency (p = 0.024), and sym-
bol digit tests (p = 0.015), as shown by the term for COPD, although the COPD patients had 
similar baseline scores on MMSE and delayed recall compared with the control group (p   1  
0.05). Control subjects had a mean decline in the MMSE score of 0.238 points/year (p   !  
0.001), 0.265 points/year on the word list recall (p   !   0.001), 0.159 points/year on the delay 
recall (p   !   0.001), 0.238 points/year on animal fluency (p   !   0.001), and 0.354 points/year on 
the symbol digit tests (p   !   0.001), as shown by the term for time. Compared with the control 
subjects, the cognitive scores in patients with COPD declined by an additional 0.219 points/
year for the MMSE (p   !   0.001), an additional 0.224 points/year for the word list recall (p   !  
0.001), an additional 0.077 points/year for delayed recall (p = 0.005), an additional 0.231 
points/year for animal fluency (p   !   0.001), and an additional 0.267 points/year for the sym-
bol digit tests (p  !  0.001), as shown by the interaction term (COPD  !  time). Cognitive func-
tions of the patients with COPD and the control group at baseline and at the 3-year follow-up 
in different domains are shown in   figure 1  .
  Discussion 
  In this hospital-based, prospective case-control study, we found that COPD was related 
to worse cognitive function at baseline and cognitive decline on the word list recall, animal 
category fluency, and symbol digit modalities over a 3-years observation period. Despite a 
Table 2. S  ummary of mixed-effect models examining the relationship of COPD to the baseline level and annual rate of 
change in different cognitive domains
COPD Time COPD ! time
B SE p value B SE p value B  SE p value
MMSE –0.221 0.218 0.313 –0.238 0.0304 <0.001 –0.219 0.0413 <0.001
Word list recall –0.874 0.364 0.016 –0.265 0.0277 <0.001 –0.224 0.0391 <0.001
Delayed recall –0.259 0.161 0.107 –0.159 0.0193 <0.001 –0.077 0.0274 <0.005
Animal fluency –0.659 0.294 0.024 –0.238 0.0295 <0.001 –0.231 0.0417 <0.001
Symbol digit –1.484 0.609 0.015 –0.354 0.0327 <0.001 –0.267 0.0467 <0.001224
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lack of association between COPD with the scores of MMSE and delayed recall at baseline, 
persons with COPD still had significant declines in mean scores of MMSE and delayed recall 
compared with control participants. Our findings extend the findings of a previous cross-
sectional study, and suggest that COPD is a significant risk factor for cognitive decline in 
older persons.
    Since the 1970s, cognitive performance has been studied in patients with COPD. The 
majority of studies have shown that patients with COPD have a higher rate of cognitive im-
pairment, either globally or in perception, memory, and psychomotor function domains 
  Fig. 1.   Cognitive functions of the patients with COPD and the control group at baseline and at the 3-year 
follow-up in different domains. 225
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  [8–16]  . However, longitudinal studies that have examined the decline in the cognitive func-
tion profile of patients with COPD and control participants by means of detailed cognitive 
tests are limited. One recent study which included 4,150 adults with a mean age of 62 years 
showed that severe COPD is associated with poorer cognitive performance on standardized 
measurements over time   [17]  . However, it was noted that the diagnosis of COPD and other 
comorbidities was based on self-report. Moreover, applying cognitive screening instruments 
does not allow for an analysis of the relationship between COPD and specific cognitive do-
mains. It is increasingly recognized that dementia may better be interpreted as a continuum 
of symptoms, rather than the mere presence or absence of a disease. Because cognitive de-
cline or dementia develops over a long preclinical period, it is difficult to reliably identify the 
factors which influence cognitive decline. A previous study suggested that timing is impor-
tant in the association between the factors which influence cognitive decline or dementia 
  [20]  . For example, a higher BMI at baseline was shown to be associated with a higher cogni-
tive decline in middle-aged men and women during follow-up   [21]  , while a low BMI in late 
life may be a preclinical indicator of underlying dementia  [22] . COPD has a deleterious effect 
on cognitive function, but the degree and range of the effect may relate to the age of patients 
with COPD. Because very elderly persons may be particularly vulnerable to pathologic pro-
cesses or diseases that cause cognitive decline, our participants with a mean age of  1 80 years 
were likely to have a rapid and more diffuse pattern of cognitive decline over a 3-year period. 
To limit the possibility that individuals with cognitive impairment would affect the associa-
tion between COPD and cognitive decline, our sample only included individuals in relative-
ly good health at baseline. On the basis of a series of medical and laboratory examinations, 
as well as a summary score on the Clinical Dementia Rating, all the participants were con-
sidered to be cognitively normal elderly. Furthermore, as very elderly persons inevitably have 
a higher prevalence of chronic disease and disability, which may relate to cognitive decline, 
participants with severe chronic disease were also excluded from the current study. Although 
there were still more COPD patients with hypertension and coronary heart disease than con-
trols, in this age- and education-matched case-control study, the baseline characteristics 
were well-balanced between the two groups. The more stringent inclusion criteria in our 
study may avoid the influence of possible confounding variables, therefore our results more 
likely reflect the effect of COPD on cognitive decline in very elderly persons using a mixed 
model adjusted for hypertension and coronary heart disease.
  A key mechanism proposed for cognitive dysfunction in COPD is neuronal damage me-
diated by hypoxia   [23]  . For example, hypoxia might cause changes in ionic channels, signal-
ing pathways, neuromodulators, and genomic processes; low acetylcholine concentrations 
have been found in the neocortex and hippocampus   [24, 25]  . However, the correlation be-
tween cognitive function and arterial oxygen tension is weak, and oxygen therapy of longer 
duration has shown no benefit of cognitive improvement in hypoxemic individuals   [23, 26]  . 
Current evidence suggests that hypoxemia alone is not enough to entirely account for the 
cognitive deficits which occur in COPD. The mechanisms of cognitive decline underlying 
COPD are probably interrelated and multifactorial, including tissue hypoxia, systemic in-
flammation, and oxidative stress   [23, 25]  . Because the elderly who have undergone annual 
routine health examinations usually prefer to be admitted to the hospital, the frequency of 
hospitalization between the case and control groups did not differ significantly. However, 
acute exacerbation is the major cause of hospitalization in patients with COPD. Some studies 
have directly addressed the deleterious impact of COPD exacerbations on cognitive function 
  [23, 27]  . Recently, a study showed that older adults who had acute care and critical illness 
hospitalizations had a greater likelihood of cognitive decline compared with older adults 
who were not hospitalized, suggesting that factors associated with acute illness may be caus-
ally related to cognitive decline   [28]  . COPD exacerbations are a common cause of acute hos-226
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pitalization. The mechanisms through which COPD exacerbation contributes to cognitive 
decline may be multiple, including hypoxemia, hypotension, systemic inflammation, and 
medications. Given that the elderly with COPD were in relatively good health and without 
oxygen dependence, we emphasize that the high frequency of COPD exacerbations, which 
trigger a complicated pathologic process, rather than chronic hypoxia only, may have con-
tributed to cognitive decline in this study.
  Our study employed a brief cognitive screening test and three domain-specific cognitive 
tests. The animal fluency is a sensitive test for detecting frontal lobe damage with deficits in 
executive functioning. The symbol digit modalities test is a measure of psychomotor speed 
and executive function and has been demonstrated to show impairment in VD. Word lists 
with immediate and delayed recall are sensitive to memory loss associated with an early stage 
of AD. In order of prevalence, AD and VD are the most common causes of dementia in el-
derly people, and subcortical ischemic vascular dementia (SIVD), due to small vessel disease, 
is clinically homogeneous and a major cause of vascular cognitive impairment and VD   [29, 
30] . Typically, memory impairment resulting from atrophy in the medial temporal lobe is the 
first sign of AD, while SIVD is characterized by deficits in attention, executive function, psy-
chomotor speed, and information processing with milder memory loss as compared with 
AD. The majority of the literature concerning cognitive impairment in patients with COPD 
points to the subcortical type with a predominant decline in attention, slower mental speed, 
and executive function   [25]  . These findings are consistent with low oxygen saturation and 
COPD being associated with more severe white matter periventricular lesions  [31] . Our study 
revealed that COPD was related to cognitive decline in multiple cognitive domains, either 
globally or in domains, such as memory, psychomotor speed, and executive function. Given 
the fact that participants with large cerebrovascular lesions/clinical stroke were excluded af-
ter detailed clinical examinations and brain CT scans, this non-specific pattern of cognitive 
decline resembles mixed SIVD/AD. The result reinforces the recent idea that mixed patholo-
gies of vascular and neurodegenerative brain injuries most likely represent the majority of 
elderly with cognitive decline   [32, 33]  . Because dementia was not formally diagnosed at the 
end of follow-up, there may be the possibility that a few of the participants in the current 
study were in an early stage of dementia. Furthermore, continued follow-up may help to un-
derstand the relationship between COPD and frank dementia.
    Our study had some limitations. First, our sample size was small, and the probability 
estimates were derived from a case-control study with the inherent weaknesses of selection 
bias. Although participants were stringently selected to avoid the influence of possible con-
founding variables, such as diabetes, cerebrovascular disease, and major chronic diseases, 
there is a possibility that other chronic or subclinical diseases which were not included in the 
analysis may also have contributed to cognitive decline. Second, we do not have measures of 
inflammatory markers related to COPD exacerbations and cognitive function, and we did 
not examine the effect of COPD severity and exacerbations on the relationship between 
COPD and cognitive decline. Finally, our sample consists of elderly men only, so the data 
may not be applicable to other data or populations with a different socioeconomic back-
ground. However, confidence in the findings of this study was strengthened by the following 
factors: cognitive performance in the hospital ward administered by specially trained exam-
iners; availability of detailed medical records and annual hospital observations with a high 
rate of follow-up, and the homogeneity of our sample which may control the effects of poten-
tially confounding variables, such as lifestyle and occupation.
    In summary, these results indicate that very elderly men with COPD have a more rapid 
and diffuse pattern of cognitive decline over a 3-year period compared with age- and educa-
tion-matched control participants.
 227
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